This inventor holds 5 USPTO granted patents and 4 published patent applications and 4 EPO patents. Top assignees: Merck Sharp & Dohme LLC, Merck Sharp + Dohme Corp.. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Anmol Gulati: Innovator in Pharmaceutical Chemistry
Introduction
Anmol Gulati is a prominent inventor based in Watertown, MA (US), known for her significant contributions to pharmaceutical chemistry. With a focus on developing innovative compounds, she has made strides in the field of drug discovery, particularly in relation to LRRK2 inhibitors.
Latest Patents
Anmol Gulati holds two notable patents. The first patent is for "1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof." This invention is directed towards certain substituted 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives that act as potent inhibitors of LRRK2 kinase. These compounds may be useful in treating or preventing diseases such as Parkinson's Disease. The invention also includes pharmaceutical compositions comprising these compounds and their applications in disease prevention and treatment.
The second patent is for "Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof." This invention focuses on reversed indazolyl-spiro[2.2]pentane-carbonitrile derivatives that serve as potent inhibitors of LRRK2 kinase. Similar to her first patent, this invention aims to provide solutions for diseases where LRRK2 kinase is involved, including Parkinson's
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile